Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
作者信息
Clemente R E
出版信息
Scand J Rheumatol. 2007 May-Jun;36(3):244-5; author reply 245. doi: 10.1080/03009740601154426.
PMID:17657687
Abstract
摘要
相似文献
1
Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
Scand J Rheumatol. 2007 May-Jun;36(3):244-5; author reply 245. doi: 10.1080/03009740601154426.
2
Demyelinating disease and cutaneous lymphocitic vasculitis after etanercept therapy in a patient with rheumatoid arthritis.
Scand J Rheumatol. 2006 Jul-Aug;35(4):322-3. doi: 10.1080/03009740600557249.
3
Leukocytoclastic vasculitis due to etanercept.
J Rheumatol. 2000 Aug;27(8):2041-4.
4
Digital vasculitis with eosinophilia possibly associated with etanercept therapy.
Acta Derm Venereol. 2014 Mar;94(2):239-40. doi: 10.2340/00015555-1662.
5
Cutaneous vasculitis induced by TNF inhibitors: a report of three cases.
Mod Rheumatol. 2010 Feb;20(1):86-9. doi: 10.1007/s10165-009-0232-7. Epub 2009 Oct 8.
6
Ophthalmic manifestations of demyelination secondary to etanercept.
Clin Exp Ophthalmol. 2008 May;36(4):392-4. doi: 10.1111/j.1442-9071.2008.001741.x.
7
[TNF-alpha inhibitors and demyelinating disease].
Lakartidningen. 2007;104(45):3384.
8
Etanercept-induced dermatitis in a patient with rheumatoid arthritis.
J Eur Acad Dermatol Venereol. 2006 May;20(5):614-5. doi: 10.1111/j.1468-3083.2006.01497.x.
9
Pulmonary rheumatoid nodules in an etanercept-treated patient.
Arthritis Rheum. 2003 Jul;48(7):2077-8. doi: 10.1002/art.11154.
10
Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.
Rheumatology (Oxford). 2008 Jun;47(6):928-9. doi: 10.1093/rheumatology/ken102. Epub 2008 Apr 2.
Zotero 插件